Geron Corporation

GERN
$1.10 (- $0.03 - 2.23%)
Last updated: 2026-06-10 19:55 UTC
GERN Metrics
Exchange
🇺🇸 NASDAQ XNGS
Nasdaq/NGS (Global Select Market)United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS3741631036
CUSIP374163103
Market Price1.09
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-0.12
Market Cap$893.7M
Book Value0.39
Price to Book3.59
Beta0.57
52w High3.68
52w Low1.04
Next Earnings DateN/A

Geron Corporation trades under ticker GERN on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US3741631036, CUSIP 374163103.

About the Company
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.
Price History